Clinical Trial Update: Twice Daily Versus Once Daily Administration of the Tacrolimus in Lung Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial comparing twice-daily versus once-daily tacrolimus in lung transplantation was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Transplantation

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Hannover Medical School | Conditions: Lung Transplantation | Phase 3 | Status: TERMINATED